Cell proliferation requires the coordinated activity of cytosolic and mitochondrial metabolic pathways to provide ATP and building blocks for DNA, RNA and protein synthesis. Many metabolic pathway genes are targets of the c-myc oncogene and cell-cycle regulator. However, the contribution of c-Myc to the activation of cytosolic and mitochondrial metabolic networks during cell-cycle entry is unknown. Here, we report the metabolic fates of [U-
Introduction
Cell proliferation is an essential component of normal growth and development, and as such, is highly regulated by hormonal and environmental factors. Although our knowledge of cell-cycle regulatory genes is advanced, the links between the cell-cycle machinery and supply of metabolic intermediates required for cell division are less well understood. Of the known transcription factors exerting cell-cycle control, a likely candidate for this regulatory function is the c-myc oncogene, due to the diversity of known target genes involved in both cell-cycle and metabolic pathways . Induction of Myc occurs rapidly in response to growth factors stimulating cell-cycle entry, with mRNA levels increasing 20-fold within the first 2 h after serum addition (Dean et al., 1986) . Global analysis of downstream targets reveals that Myc potentially regulates up to 15% of human genes through direct binding to target gene sequences , and may have even broader effects on gene expression through global chromatin remodeling (Knoepfler et al., 2006) . Notably, Myc regulates key genes in glycolysis, C1/ folate, purine, pyrimidine and lipid metabolism (Dang et al., 2006; Zeller et al., 2006) . In addition, Myc targets genes required for mitochondrial DNA replication and transcription (Li et al., 2005) . Hence, Myc supports the bigenomic transcriptional regulation necessary for mitochondrial biogenesis, a key event during cell-cycle entry (Mandal et al., 2005; Morrish et al., 2008) . In summary, the network of known Myc gene targets suggests that Myc is involved in orchestrating the changes in cell metabolism necessary for cell-cycle entry. However, to the best of our knowledge, there have been no studies of central carbon metabolic flux or carbon partitioning associated with physiological Myc expression. Our goal in this study was to address this question.
Results and discussion
Myc increases oxidative metabolism of glucose during cell-cycle entry Rat1A fibroblasts with myc À/À and myc þ / þ genotypes were incubated with [U- 13 C]-labeled glucose starting at 12 h after serum addition to quiescent cells. The metabolic fates of 13 C atoms can be assessed in a wide range of metabolites based on the resonant absorption signals of 13 C nuclei when placed in an external magnetic field. The positions of 13 C tracer in the carbon backbone of metabolites vary according to the proportional fluxes of alternate metabolic pathways, which can be derived by measurements of the relative abundance of the different labeling patterns. NMR spectroscopy was performed on cell extracts after 4 h of labeling to approximate steady state for analysis of 13 C-labeled metabolites. This allowed us to compare the metabolic profiles during the G 0 -to S-phase transition of myc þ / þ cells, which enter S phase at 16 h, and myc À/À cells, which have delayed S-phase entry (Schorl and Sedivy, 2003; Tollefsbol and Cohen, 1990) . Figure 1a shows representative 1 H-decoupled, 13 C NMR spectra from cell extracts. Figure S1 ). This was confirmed by quantitative mass isotopomer analysis using LC/MS/MS (liquid chromatography/mass spectrometry/mass spectrometry). We detected a 20% increase in the fractional contribution of 13 C-labeled glutamate to the total glutamate pool in myc þ / þ cells compared to myc À/À cells ( Figure 1c ). Glutamate is in equilibrium with aketoglutarate and can be used to assess tricarboxylic acid (TCA) cycle flux using the program tcaCALC (UT Southwestern Medical Center, Dallas, TX, USA) (Malloy et al., 1990) . In our experiments, the multiplet resonances of glutamate were well resolved (Supplementary Figure S1 ) and the areas of the glutamate C2, C3 and C4 resonances were used to calculate relative flux of glucose carbons into the TCA cycle by pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC).
Results of this analysis, illustrated in Figure 1b , C pyruvate to the total oxaloacetate pool by pyruvate carboxylation. These results identify significant qualitative differences between myc þ / þ and myc À/À cells in substrate partitioning and pathway flux into the TCA cycle during preparation for S-phase entry, consistent with observed differences in serum-induced changes in mitochondrial mass and respiration (Morrish et al., 2008) .
The Myc-dependent alterations in TCA cycle and related fluxes can be explained by changes in Mycregulated gene expression. Induction of Myc (MycER) in myc À/À cells results in temporal repression of PDK2 and PDK4 (Morrish et al., 2008) , which would lead to increased pyruvate oxidation by decreasing inhibitory phosphorylation of PDH. Expression of PC is also temporally decreased by Myc induction, reinforcing the allocation of pyruvate to supply the mitochondrial acetyl-CoA pool. These results, together with the effects of Myc on mitochondrial bioenergetics during cell-cycle entry, point to a key function for Myc in augmenting mitochondrial capacity and directing substrates to mitochondria during the transition from maintenance energy requirements of quiescent cells to the active biosynthesis of cycling cells (Morrish et al., 2008) .
Myc increases glucose carbon flux into branch metabolic pathways of glycolysis Metabolism of glucose supplies intermediates for amino-acid synthesis, C1/folate metabolism, and pentose phosphate and hexosamine biosynthetic pathways, in addition to lactate generation. We found evidence for increased glycolytic flux as 13 C labeling of lactate was greater in myc (Figure 2a ). This result was expected, as multiple glycolytic genes are targets of Myc (Osthus et al., 2000) , and we have previously shown increased conversion of glucose to pyruvate and lactate in Rat1A myc þ / þ cells compared to myc À/À cells (Morrish et al., 2008 ). When we evaluated the spectra for additional 13 Cenriched intermediary metabolites, we found increased levels of 13 C-labeled alanine and glycine, derived from pyruvate and the glycolytic intermediate 3-phosphoglycerate, respectively (Figure 2b and c) . Glycine is a precursor for de novo purine synthesis as well as a carbon donor for C1/folate metabolism required for nucleotide biosynthesis. We observed 13 C labeling of the C2 position in the adenine base, originating from N10-formyl-tetrahydrofolate, as well as increased incorporation of 13 C into the ribose moiety of nucleotides, demonstrated by a threefold increase in ribose C4 0 labeling (Figure 2d ). Folate is required for one-carbon transfer reactions in purine and thymidylate biosynthesis, as well as epigenetic modification of DNA and proteins. Expression of B50% of genes involved in folate metabolism is increased following Myc induction (Morrish et al., 2008) , and SHMT2 is one of only two Myc target genes results shown to complement growth defects in myc À/À cells (Nikiforov et al., 2002) . Treatment with the dihydrofolate reductase inhibitor, methotrexate, inhibited growth of myc þ / þ cells more effectively than myc À/À cells (Figure 3c ). Similar results were obtained using myc À/À cells transfected with inducible Myc (myc À/À MycER) (Figure 3c ). These results provide additional evidence of the close relationship between nucleotide synthesis and Myc-dependent cell proliferation (Mannava et al., 2008) , and establish direct links between increased glucose metabolism and nucleotide synthesis in Myc-expressing cells.
Myc increases phosphocholine levels
Phosphocholine is an intermediate in phosphatidylcholine (PtdCho) synthesis and is required for membrane biosynthesis during cell-cycle entry (Jackowski, 1994) . Because phosphocholine is difficult to quantitate in 13 C spectra due to spectral overlap, we used 1D-1 H spectra to evaluate phosphocholine content. We found a threefold increase in phosphocholine levels in serumstimulated myc þ / þ cells compared to myc À/À cells (Figure 3a) . Myc induction increases choline kinase expression (Morrish et al., 2008) , and elevated phosphocholine levels are associated in neuroblastomas with N-Myc amplification (Peet et al., 2007) . The ratelimiting enzyme in PtdCho synthesis, CTP:phosphocholine cytidylyltransferase (CCT/PCYT1A), is also an Myc target gene (Li et al., 2003) , suggesting Myc increases glycerophospholipid synthesis. The increased TCA cycle flux observed in myc þ / þ cells may also have a function in increased glycerophospholipid synthesis by generating acetyl groups required for de novo fatty acid synthesis. In preliminary results, we observed that fatty acid synthesis from [U- (Morrish, unpublished data) . These results may be relevant to the delayed cell-cycle entry of myc À/À cells, as net accumulation of PtdCho near the G 1 /S boundary is necessary for membrane synthesis (Jackowski, 1994) . PtdCho is also a source of lipid second messengers involved in cell-cycle progression (Hunt and Postle, 2004) .
O-GlcNAc posttranslational modification is regulated by Myc
Glycolytic (fructose-6-phosphate) and TCA cycle intermediates (glutamine, acetyl-CoA) are substrates for the hexosamine biosynthesis pathway (HBP). Because the 13 C data demonstrated increased glycolytic and TCA cycle flux in serum-stimulated myc þ / þ cells, we looked
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Immunoblotting of cell extracts using an O-GlcNAc-specific antibody detected multiple bands, with an overall temporal increase after serum addition in myc þ / þ cells. Several bands were detected at lower intensity in serum-starved cells, whereas others appeared with serum stimulation (Figure 3b ). The number of O-GlcNAc-modified proteins detected in myc À/À cells was reduced and the serum response significantly attenuated.
Increased O-GlcNAc protein modification may result from increased expression of modifying enzyme, O-GlcNAc transferase (OGT), and/or increased hexosamine synthesis. OGT protein expression was reduced as demonstrated by immunoblotting in myc þ / þ cells compared to myc À/À cells under serum-deprived conditions and an early response to serum was not observed (Figure 3c ). Hence, early Myc-associated increases in protein O-GlcNAcylation are not explained by upregulation of OGT expression.
To examine the function of O-GlcNAcylation in Mycdependent proliferation, we treated cells with 6-diazo-5-oxo-L-norleucine (DON), an inhibitor of glutamine:-fructose-6-phosphate aminotransferase (GFAT), the first and rate-limiting enzyme of the hexosamine pathway. Both myc þ / þ and induced myc À/À MycER cells were more sensitive to growth inhibition at 48 h, suggesting an important function for the HBP during proliferation in myc þ / þ cells (Figure 3d ). O-GlcNAc protein modification is a dynamic process analogous to phosphorylation (Hart et al., 2007) . Interference with O-GlcNAc modification has been shown to disrupt cell-cycle progression (Slawson et al., 2005) . Several Metabolic flux analysis of Myc-dependent cell-cycle entry F Morrish et al HBP genomic loci are bound by Myc, including GNS and NAGPA (Li et al., 2003) and HBP genes are enriched in expression profiling of Myc-induced pancreatic neoplasia (Lawlor et al., 2006) . In addition to transcriptional regulation of the HBP, Myc may increase the supply of essential substrates for hexosamine biosynthesis as a consequence of the increased glycolytic and TCA cycle fluxes demonstrated by 13 C isotopomer analysis. In conclusion, our results demonstrate the broad effects of endogenous Myc expression on glucose carbon flux in both catabolic and anabolic pathways, in response to serum stimulation, including glycolysis, the TCA cycle, the pentose phosphate pathway and C1/folate metabolism (Figure 4) . The obligate function of mitochondria in C1/folate metabolism raises the possibility that Myc-induced mitochondrial biogenesis provides for biosynthesis of key intermediate metabolites in addition to bioenergetic requirements for cell-cycle progression. This extensive programming of metabolism may be unique to Myc. For example, HIF-1a directs increased glycolytic metabolism, but at the expense of anabolic synthesis and mitochondrial respiration (Lum et al., 2007) . Finally, the observation of Myc effects on O-GlcNAc posttransla- Metabolic flux analysis of Myc-dependent cell-cycle entry F Morrish et al tional protein modification provides an interesting example of the potential intersection of metabolome and transcriptome networks for signal amplification and integration.
